Amyloidosis Community Survey
This survey has now ended. Thank you to everyone who participated and has helped guide the future of Amyloidosis Research.
Participate in Future ARC Surveys →
For the past four years, the ARC Amyloidosis Community survey has collected information on the amyloidosis community’s experience with diagnosis and treatment. These critical annual surveys highlight the voice of our community and shape the future of patients and their families. Insights from the survey will also help inform and develop future ARC initiatives and programs to best support the patients and caregivers we serve.
Electronic Informed Consent: Your participation in this study does not involve any risk to you beyond that of everyday life. The benefit of participating in this survey is that it may provide insights on this to further understand and describe the experience with diagnosis and treatment of patients with amyloidosis and their caregivers. The study’s results will be used to help advocate for care, treatment, and program needs of the amyloidosis community. Participation in this survey is completely voluntary and you may exit this survey at any time. Refusal to participate will involve no penalty. View the detailed research consent (Deutsch, Español, Português, Italiano, Français). By clicking on the survey link, you are agreeing to participate in this survey.
